ARCH THERAPEUTICS, INC.: 10-Q filed 2016-02-12

Name: ARCH THERAPEUTICS, INC.: 10-Q filed 2016-02-12
Creator: ARCH THERAPEUTICS, INC.

What ARCH THERAPEUTICS, INC. reported in its quarterly report filed 2016-02-12 (fiscal Q1 2016): 21 published measures, 44 facts as tagged in accession 0001144204-16-081344.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-02-12
Fiscal period: fiscal Q1 2016
Accession: 0001144204-16-081344 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARCH THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-12-31	2,868,409	USD
At 2015-09-30	4,003,019	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-12-31	1,958,514	USD
At 2015-09-30	2,462,902	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-12-31	909,895	USD
At 2015-09-30	1,540,117	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-12-31	2,815,449	USD
At 2015-09-30	3,960,100	USD
At 2014-12-31	782,675	USD
At 2014-09-30	833,520	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-1,156,655	USD	92
2014-10-01 to 2014-12-31	379,145	USD	92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	0	USD	92
2014-10-01 to 2014-12-31	0	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-12-31	-16,878,875	USD
At 2015-09-30	-15,722,220	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	108,620,575	shares	92
2014-10-01 to 2014-12-31	73,422,007	shares	92

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-0.01	USD/shares	92
2014-10-01 to 2014-12-31	0.01	USD/shares	92

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	148,037	USD	92
2014-10-01 to 2014-12-31	278,212	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-1,279,515	USD	92
2014-10-01 to 2014-12-31	-1,270,090	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-12-31	2,868,409	USD
At 2015-09-30	4,003,019	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	143,747	USD	92
2014-10-01 to 2014-12-31	27,765	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-12-31	748,675	USD
At 2015-09-30	1,286,078	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-12-31	267,863	USD
At 2015-09-30	231,761	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	1,279,515	USD	92
2014-10-01 to 2014-12-31	1,270,090	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	414,003	USD	92
2014-10-01 to 2014-12-31	399,735	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-12-31	109,171,684	shares
At 2015-09-30	107,592,205	shares

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2015-12-31	52,960	USD
At 2015-09-30	42,919	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	865,512	USD	92
2014-10-01 to 2014-12-31	870,355	USD	92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	36,102	USD	92
2014-10-01 to 2014-12-31	118,350	USD	92

Inspect the source

Entity: ARCH THERAPEUTICS, INC. / CIK 0001537561
Captured: 2026-09-22 19:51 UTC
SEC response SHA-256: 63d0e84748ee59ab7c6817be68d0a32b23d83273213bc50081bb86253a1d4cc2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001537561.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))